Royal Bank of Canada »

Arrivent Biopharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-06-30 $0 927 0.00
2024-03-31 $7.7k 369 20.83

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Bk Nova Cad (BNS)
Enbridge (ENB)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
FMR
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation

View all funds holding Arrivent Biopharma